TD Private Client Wealth LLC Has $2.93 Million Stock Position in Colgate-Palmolive Company $CL

TD Private Client Wealth LLC raised its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 1,485.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 36,616 shares of the company’s stock after buying an additional 34,307 shares during the quarter. TD Private Client Wealth LLC’s holdings in Colgate-Palmolive were worth $2,927,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Westside Investment Management Inc. raised its stake in Colgate-Palmolive by 85.5% during the 2nd quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock valued at $26,000 after purchasing an additional 130 shares during the last quarter. Vermillion & White Wealth Management Group LLC raised its position in shares of Colgate-Palmolive by 86.1% during the second quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock valued at $30,000 after buying an additional 155 shares during the last quarter. MTM Investment Management LLC acquired a new position in shares of Colgate-Palmolive during the second quarter valued at about $39,000. Louisbourg Investments Inc. lifted its stake in shares of Colgate-Palmolive by 94.7% in the third quarter. Louisbourg Investments Inc. now owns 514 shares of the company’s stock valued at $41,000 after buying an additional 250 shares during the period. Finally, Atticus Wealth Management LLC increased its stake in Colgate-Palmolive by 156.8% during the second quarter. Atticus Wealth Management LLC now owns 488 shares of the company’s stock valued at $44,000 after acquiring an additional 298 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 1.3%

Shares of Colgate-Palmolive stock opened at $82.99 on Wednesday. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $100.18. The stock has a market capitalization of $66.90 billion, a P/E ratio of 23.25, a price-to-earnings-growth ratio of 5.55 and a beta of 0.30. The company has a 50-day simple moving average of $78.98 and a 200 day simple moving average of $81.82. The company has a quick ratio of 0.60, a current ratio of 0.93 and a debt-to-equity ratio of 5.90.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, October 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.89 by $0.02. The firm had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.17 billion. Colgate-Palmolive had a net margin of 14.47% and a return on equity of 333.39%. The company’s quarterly revenue was up 1.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.91 earnings per share. Research analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 21st will be issued a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend is Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 58.26%.

Analysts Set New Price Targets

A number of brokerages have commented on CL. Royal Bank Of Canada upgraded Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price objective for the company in a research report on Tuesday, December 9th. Barclays reduced their target price on Colgate-Palmolive from $82.00 to $80.00 and set an “equal weight” rating for the company in a research report on Tuesday, November 4th. TD Cowen lowered their price target on shares of Colgate-Palmolive from $90.00 to $86.00 and set a “buy” rating on the stock in a report on Thursday, January 8th. The Goldman Sachs Group reduced their price objective on shares of Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating for the company in a report on Thursday, October 2nd. Finally, Jefferies Financial Group set a $85.00 target price on shares of Colgate-Palmolive in a research note on Tuesday, December 16th. Eleven investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $88.75.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.